Insights

Niche Market Focus ATI Pharma specializes in over-the-counter therapeutics aimed at modulating body functions to enhance quality of life, presenting opportunities to collaborate with wellness clinics, health stores, and DIY healthcare consumers seeking evidence-based alternative therapies.

Emerging Market Entry Following a successful test market in Canada, ATI’s recent product license acquisition indicates expansion potential into North American retail channels and online platforms, providing avenues for distribution partners and e-commerce collaborations.

Innovative Technology Stack Utilizing modern web technologies like Duda and Open Resty suggests an emphasis on digital engagement and e-commerce capabilities, enabling sales teams to explore partnerships with online health and supplement retailers or direct-to-consumer sales channels.

Small but Strategic Despite a modest team size and revenue below one million dollars, ATI Pharma's strategic positioning as a targeted OTC provider offers opportunities for niche marketing, contract manufacturing, and cooperative branding with larger pharmaceutical players.

Growth Opportunities With a mission focused on becoming the most valued OTC pharmaceutical company, ATI presents growth prospects through product expansion, market penetration, and forming alliances with larger competitors seeking innovative supplement solutions for health-conscious consumers.

ATI Pharma Tech Stack

ATI Pharma uses 8 technology products and services including Duda, Open Graph, MobX, and more. Explore ATI Pharma's tech stack below.

  • Duda
    Content Management System
  • Open Graph
    Content Management System
  • MobX
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Priority Hints
    Performance
  • Java
    Programming Languages
  • YouTube
    Video Players
  • OpenResty
    Web Servers

Media & News

ATI Pharma's Email Address Formats

ATI Pharma uses at least 1 format(s):
ATI Pharma Email FormatsExamplePercentage

Frequently Asked Questions

What is ATI Pharma's official website and social media links?

Minus sign iconPlus sign icon
ATI Pharma's official website is atipharma.com and has social profiles on LinkedIn.

What is ATI Pharma's NAICS code?

Minus sign iconPlus sign icon
ATI Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ATI Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, ATI Pharma has approximately employees across 1 continents, including Asia. Key team members include . Explore ATI Pharma's employee directory with LeadIQ.

What industry does ATI Pharma belong to?

Minus sign iconPlus sign icon
ATI Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does ATI Pharma use?

Minus sign iconPlus sign icon
ATI Pharma's tech stack includes DudaOpen GraphMobXjQueryPriority HintsJavaYouTubeOpenResty.

ATI Pharma

Pharmaceutical ManufacturingColorado, United States0-1 Employees

Our Mission is to become a leading Global OTC Pharmaceutical Company and to provide evidence-based alternative and/or additive therapies. Our goal at ATI is to offer OTC Pharmaceuticals whose mechanism of action may modulate, balance or enhance the ability to regulate the structure and function of the body which in turn contributes to a higher quality of life. Our Vision is to become the worlds most valued “over the counter “Pharma Company for patients, customers, colleagues, investors & business partners. ATI purchased this product license after a very well received test market in Canada.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
0-1

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    ATI Pharma's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    ATI Pharma's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.